Pattern of blood transfusion request and utilization at a Nigerian University Teaching Hospital

Autor: Abubakar U Musa, Mohammed A Ndakotsu, Abdul-Aziz Hassan, Ayatollah Kilishi, Ibrahim K Kwaifa

Publikováno v: Sahel Medical Journal, Vol 17, Iss 1, Pp 19-22 (2014)

Introduction: Provision of adequate safe blood is challenging in developing countries due to paucity of voluntary blood donors, poor facilities for storage and blood component preparation as well as inappropriate blood ordering and utilization. Appra

Externí odkaz: https://doaj.org/article/375878b1354a447d8974d5b2f0734986

The Relationship between Macroeconomic Variables and Housing Prices in Saudi Arabia Using Vector Auto-Regression Analysis.

Autor: Ahmed, Dirar Elmahi Elobeid¹ de.ahmed@qu.edu.sa, Mohammed, Khaled Abdul Aziz Hassan² khald_aziz32@yahoo.com

Publikováno v: Rihan Journal for Science Publishing. 2022, Issue 20, p18-42. 25p.

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version 1; referees: 2 approved]

Autor: Baba Psalm Duniya Inusa, Atoyebi Wale, Abdul Aziz Hassan, Tushar Idhate, Livingstone Dogara, Ifeoma Ijei, Yewen Qin, Kofi Anie, Juliana Olufunke Lawson, Lewis Hsu

Publikováno v: F1000Research, Vol 7 (2018)

The multiple clinical benefits of hydroxycarbamide in sickle cell disease are supported by a large body of evidence. The maximum tolerated dose (MTD) is the regimen recommended by guidelines from a panel of National Heart, Lung, and Blood Institute (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::182e52cf3e84f0c3fc6c633b4401d9d6
https://f1000research.com/articles/7-1407/v1

Primary Acquired Melanosis: Clinical, Histopathologic and Optical Coherence Tomographic Correlation.

Autor: Alzahrani, Yahya A., Kumar, Smita, Abdul Aziz, Hassan, Plesec, Thomas, Singh, Arun D.

Publikováno v: Ocular Oncology & Pathology; Apr2016, Vol. 2 Issue 3, p123-127, 5p

Acceptability, barriers and facilitators of using dried blood spots-point-of-care testing for sickle cell disease in Africa: an implementation science protocol for a multinational qualitative study

Autor: Andre Pascal Kengne, Leon Tshilolo, Grace Ndeezi, Nicola Mulder, Moses Joloba, Victoria Nembaware, Nchangwi Syntia Munung, Vivian Paintsil, Emmanuel Peprah, Fred Stephen Sarfo, Deogratias Munube, Collen Masimirembwa, Ambroise Wonkam, Daniel Ansong, Kwaku Ohene-Frempong, Ezekiel Mupere, Sarah Kiguli, Julie Makani, Josephine Mgaya, Siana Nkya, Fred Semitala, Raphael Zozimus Sangeda, Emmanuel Balandya, Anazoeze Madu, Catherine Chunda-Liyoka, Yeya Dit Sadio Sarro, Daudi Jjingo, Obiageli Eunice Nnodu, Lulu Chirande, Boubacari Ali Touré, Aldiouma Guindo, Patience Kuona, Kevin Esoh, Mario Jonas, Maxwell Nwegbu, Upendo Masamu, Jack Morrice, Patrick Ohiani Moru, Valentina Ngo Bitoungui, Hans Ackerman, Alex Osei Akoto, Emmanuela Ambrose, Evans Amuzu, Samuel Asala, Biobele Brown, Mmbando Bruno, Daima Bukini, Pamela Gorejena, Abdul Aziz Hassan, Justin Hokororo, Jade Hotchkiss, Abdoul Malik Idris, Hezekiah Isa, Agnes Jonathan, Gwendoline Q. Kandawasvika, Daniel Kandonga, Ibrahima Keita, Sekou Kene, Frank Makundi, Janeth Manongi, Hamakwa Mantina, Jason Maro, Irene Kida Minja, Khuthala Mnika, Takudzwa Mtisi, Wilson Mupfururirwa, Ritah Mutagonda, Ruth Namazzi, Solomon Ofori-Aquah, Emmanuel Okocha, Fumni Olopade, Jesca Ondego, Chandré Oosterwyk-Liu, Nash Oyekanmi, Stella Paul, Cynthia Phiri, Paschal Ruggajo, Parker Ruhl, Ian Machingura Ruredzo, Pauline Sambo, Sawabati Shabani, Florence Urio, Robert Opoka

Publikováno v: BMJ Open, Vol 14, Iss 11 (2024)

Background Sickle cell disease (SCD) is a prevalent inherited blood disorder. Globally, approximately 515 000 babies are born with SCD annually, with 75% of these births occurring in Africa. Integrating newborn screening (NBS) for SCD into primary he

Externí odkaz: https://doaj.org/article/071fae27709947318206425d2fa31a68